par Baruteau, Julien;Nyabi, Omar;Najimi, Mustapha;Sokal, Etienne M;Fauvart, Maarten 
Référence Journal of pediatric endocrinology & metabolism, 27, 9-10, page (863-868)
Publication Publié, 2014-09
Référence Journal of pediatric endocrinology & metabolism, 27, 9-10, page (863-868)
Publication Publié, 2014-09
Article révisé par les pairs
| Résumé : | Phenylketonuria (PKU) is one of the most prevalent inherited metabolic diseases and is accountable for a severe encephalopathy by progressive intoxication of the brain by phenylalanine. This results from an ineffective L-phenylalanine hydroxylase enzyme (PAH) due to a mutated phenylalanine hydroxylase (PAH) gene. Neonatal screening programs allow an early dietetic treatment with restrictive phenylalanine intake. This diet prevents most of the neuropsychological disabilities but remains challenging for lifelong compliance. Adult-derived human liver progenitor cells (ADHLPC) are a pool of precursors that can differentiate into hepatocytes. We aim to study PAH expression and PAH activity in a differenciated ADHLPC. ADHLPC were isolated from human hepatocyte primary culture of two different donors and differenciated under specific culture conditions. We demonstrated the high expression of PAH and a large increase of PAH activity in differenciated LPC. The age of the donor, the cellular viability after liver digestion and cryopreservation affects PAH activity. ADHLPC might therefore be considered as a suitable source for cell therapy in PKU. |
